How small biotech can overcome clinical trial hurdles

How small biotech can overcome clinical trial hurdles

Small biotech companies are responsible for a significant proportion of newly approved medicines, especially for rare diseases. But with limited resources, budget constraints and a lean structure, they face many challenges before they can help patients. Here we look...